经鼻高流量治疗对稳定期慢阻肺患者经皮二氧化碳分压的影响:随机交叉对照试验
该单盲随机交叉对照试验纳入48例稳定期慢阻肺患者,比较15、30、45 L/min经鼻高流量与室内空气对20分钟时经皮二氧化碳分压(PtCO2)的影响。结果显示,30和45 L/min可小幅降低PtCO2并减少呼吸频率,效应呈流量依赖性。
要点
- 经鼻高流量30和45 L/min可小幅降低稳定期慢阻肺患者PtCO2。
- 经鼻高流量降低呼吸频率,效应随流量增加而增强。
- 15 L/min对PtCO2的降低未达统计学显著性。
核心结论
- 经鼻高流量治疗在稳定期慢阻肺患者中产生小幅、流量依赖性的PtCO2和呼吸频率降低。
研究设计与样本
- 单盲随机交叉对照试验,48例慢阻肺患者随机接受四种20分钟干预:经鼻高流量15、30、45 L/min或室内空气,干预间洗脱15分钟。
主要发现
- 20分钟时PtCO2平均变化(95%CI)较室内空气:15 L/min为-0.6 mmHg(-1.1至0.0),P=0.06;30 L/min为-1.3 mmHg(-1.9至0.8),P<0.001;45 L/min为-2.4 mmHg(-2.9至-1.8),P<0.001。
- 20分钟时呼吸频率平均变化(95%CI)较室内空气:15 L/min为-1.5次/分(-2.7至-0.3),P=0.02;30 L/min为-4.1次/分(-5.3至-2.9),P<0.001;45 L/min为-4.3次/分(-5.5至-3.1),P<0.001。
临床怎么用
- 对稳定期慢阻肺患者,经鼻高流量30-45 L/min可能小幅改善高碳酸血症和呼吸频率,但需结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Hypercapnia is associated with worse clinical outcomes in exacerbations of COPD. The present study aimed to determine the effects of nasal high flow (NHF) therapy on transcutaneous partial pressure of carbon dioxide (PtCO2 ) in stable COPD patients. METHODS: In a single-blind randomized controlled cross-over trial, 48 participants with COPD were allocated in random order to all of four 20 min interventions: NHF at 15 L/min, 30 L/min and 45 L/min or breathing room air with each intervention followed by a washout period of 15 min. The primary outcome measure was PtCO2 at 20 min, adjusted for baseline PtCO2 . Secondary outcomes included respiratory rate at 20 min, adjusted for baseline. RESULTS: The mean (95% CI) change in PtCO2 at 20 min was -0.6 mm Hg (-1.1 to 0.0), P = 0.06; -1.3 mm Hg (-1.9 to 0.8), P < 0.001; and -2.4 mm Hg (-2.9 to -1.8), P < 0.001; for NHF at 15 L/min, 30 L/min and 45 L/min compared with room air, respectively. The mean (95% CI) change in respiratory rate at 20 min was -1.5 (-2.7 to -0.3), P = 0.02; -4.1 (-5.3 to -2.9), P < 0.001; and -4.3 (-5.5 to -3.1), P < 0.001; breaths per minute compared with room air, respectively. CONCLUSION: NHF results in a small flow-dependent reduction in PtCO2 and respiratory rate in patients with stable COPD.
引用
- McKinstry S, Pilcher J, Bardsley G, et al. Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial. Respirology. 2017. PMID: 28940962. doi:10.1111/resp.13185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。